Compare DexCom, Inc. (DXCM) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Verizon Communications Inc — how do they compare? DexCom, Inc. trades at $77.36 (market cap $28.06B), while Verizon Communications Inc trades at $44.03 (market cap $178.84B). The key difference: Verizon Communications Inc is far larger — about 6.4× DexCom, Inc.'s market cap, and Verizon Communications Inc pays a 6.61% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | VZ | |
|---|---|---|
Market Cap | $28.06B | $178.84B |
Sector | Health | Media |
52-Week High | $89.53 | $51.38 |
52-Week Low | $54.84 | $38.40 |
Enterprise Value | $27.03B | $366.35B |
Volume | — | 22,584,735 |
Dividend Yield | — | 6.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Verizon (VZ) trades at $43.93, up 3.44% on the day, with a bearish technical signal but strong fundamentals including a P/E of 10.45 and a 6.66% dividend yield. Recent earnings beats and raised FY 2026 EPS guidance to $4.95–$4.99 reflect operational strength, though competition and technical weakness pose challenges. Cash flow trends show improving net cash generation, rising from $1.1B in 2024 to $14.9B in 2025.
The outlook is mixed: valuation appears attractive with a consensus price target of $48.06, but Starlink competition and bearish technicals present risks. Upside hinges on execution of growth initiatives and dividend sustainability, while downside could stem from industry disruption or earnings misses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
